申请人:Merck Sharp & Dohme Corp.
公开号:US20150182503A1
公开(公告)日:2015-07-02
The present invention is directed to compounds of the Formula I: as well as pharmaceutically acceptable salts thereof, that may be useful for treating aldosterone-mediated diseases. The invention furthermore relates to specific diastereomers and enantiomers of the compounds, to processes for preparing compounds of the Formula I, to their potential use for the therapy and prophylaxis of the above-mentioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical compositions which comprise compounds of the Formula I.
本发明涉及公式I的化合物,以及其药学上可接受的盐,这些化合物可能有用于治疗醛固酮介导的疾病。此外,本发明还涉及该化合物的特定对映体和立体异构体,制备公式I化合物的过程,它们在上述疾病的治疗和预防以及为此目的制备制药的潜在用途,以及包括公式I化合物的药物组合物。